Surgical revascularization in patients with poor left ventricular function: on- or off-pump?

Hani Shennib1, Munemoto Endo, Osama Benhamed

  • 1Division of Cardiothoracic Surgery, The Montreal General Hospital, Quebec, Canada. hani.shennib@muhc.mcgill.edu

Insights

Off-pump coronary artery bypass (OPCAB) offers favorable outcomes for patients with poor left ventricular function, demonstrating lower mortality and reduced blood transfusion needs compared to conventional coronary artery bypass (CCAB). This surgical revascularization approach appears safe and effective in high-risk individuals.

Area of Science:

  • Cardiovascular Surgery
  • Cardiac Surgery Outcomes
  • Minimally Invasive Cardiac Procedures

Background:

  • Patients with left ventricular dysfunction and low ejection fraction (EF) face elevated risks during coronary artery bypass grafting (CABG).
  • The efficacy of off-pump coronary artery bypass (OPCAB) in this high-risk cohort remains an area of investigation.
  • This study compares OPCAB and conventional coronary artery bypass (CCAB) outcomes in patients with impaired left ventricular function.

Observation:

  • A retrospective analysis included 77 patients with EF ≤ 0.35 undergoing isolated CABG between 1998 and 2001.
  • Operative mortality was 3.2% for OPCAB versus 10.9% for CCAB (p=0.39).
  • OPCAB patients required fewer blood transfusions (p<0.05) and distal anastomoses (p<0.01), but had a higher incidence of atrial fibrillation (p<0.05).

Findings:

  • Off-pump coronary artery bypass (OPCAB) demonstrated comparable safety and potentially better outcomes in patients with poor left ventricular function.
  • The reduced number of grafts in OPCAB did not negatively impact clinical results.
  • Intraaortic balloon pump use was minimal in both groups.

Implications:

  • Off-pump CABG is a viable surgical revascularization option for high-risk patients with reduced ejection fraction.
  • Further research may explore optimizing graft strategies in OPCAB for this population.
  • These findings support the consideration of OPCAB in selected patients with severe left ventricular dysfunction.
Abstract

Related Concept Videos

Cardiac Catheterization III: Left Heart Catheterization01:24

Cardiac Catheterization III: Left Heart Catheterization

Left heart catheterization is an invasive diagnostic procedure used to evaluate the function and structure of the left side of the heart. It is generally performed to diagnose and treat cardiovascular conditions such as valve abnormalities, coronary artery disease, and congenital heart defects.Diagnostic and therapeutic purposesLeft heart catheterization serves various diagnostic and therapeutic purposes, including:Assessing coronary artery bypass grafts.Evaluating coronary artery disease in...
Aortic Regurgitation III: Medical Management01:25

Aortic Regurgitation III: Medical Management

Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Cardiomyopathy VII: Pre and Post Operative Nursing Management01:28

Cardiomyopathy VII: Pre and Post Operative Nursing Management

Patients with hypertrophic cardiomyopathy (HCM) and left ventricular outflow tract (LVOT) obstruction who remain symptomatic despite optimal medical therapy may undergo a septal myectomy (Morrow procedure). This procedure involves excising a portion of the hypertrophied septum below the aortic valve using a heart-lung machine to improve blood flow through the LVOT. Effective preoperative and postoperative nursing management ensures successful patient outcomes, minimizes complications, and...